These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 35611119)
1. An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2. Shang L; Zhang Y; Liu Y; Jin C; Zhao Y; Zhang J; Wang PH; Wang J STAR Protoc; 2022 Jun; 3(2):101406. PubMed ID: 35611119 [TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples. Banerjee A; Pai MGJ; Singh A; Nissa MU; Srivastava S STAR Protoc; 2022 Mar; 3(1):101177. PubMed ID: 35233542 [TBL] [Abstract][Full Text] [Related]
3. A TurboID-based proximity labelling approach for identifying the DNA-binding proteins. Wei XF; Li S; Hu JL STAR Protoc; 2023 Mar; 4(1):102139. PubMed ID: 36861822 [TBL] [Abstract][Full Text] [Related]
4. A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. May DG; Martin-Sancho L; Anschau V; Liu S; Chrisopulos RJ; Scott KL; Halfmann CT; Díaz Peña R; Pratt D; Campos AR; Roux KJ Viruses; 2022 Mar; 14(3):. PubMed ID: 35337019 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling. Lai DY; Jiang HW; Li Y; Zhang HN; Tao SC STAR Protoc; 2022 Jun; 3(2):101238. PubMed ID: 35310073 [TBL] [Abstract][Full Text] [Related]
6. Protocol to identify host-viral protein interactions between coagulation-related proteins and their genetic variants with SARS-CoV-2 proteins. Holcomb DD; Jankowska KI; Hernandez N; Laurie K; Kames J; Hamasaki-Katagiri N; Komar AA; DiCuccio M; Kimchi-Sarfaty C STAR Protoc; 2022 Sep; 3(3):101648. PubMed ID: 36052345 [TBL] [Abstract][Full Text] [Related]
7. Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques. Cottignies-Calamarte A; He F; Zhu A; Real F; Bomsel M STAR Protoc; 2023 Dec; 4(4):102593. PubMed ID: 37738115 [TBL] [Abstract][Full Text] [Related]
8. Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4. Zandian M; Jang SM; Lachance C; Acharya A; Byrareddy SN; Côté J; Kutateladze TG STAR Protoc; 2022 Dec; 3(4):101853. PubMed ID: 36595918 [TBL] [Abstract][Full Text] [Related]
9. Super-resolution proximity labeling reveals anti-viral protein network and its structural changes against SARS-CoV-2 viral proteins. Lee YB; Jung M; Kim J; Charles A; Christ W; Kang J; Kang MG; Kwak C; Klingström J; Smed-Sörensen A; Kim JS; Mun JY; Rhee HW Cell Rep; 2023 Aug; 42(8):112835. PubMed ID: 37478010 [TBL] [Abstract][Full Text] [Related]
10. A qualitative IgG ELISA for detection of SARS-CoV-2-specific antibodies in Syrian hamster serum samples. Shete A; Mohandas S; Jain R; Yadav PD STAR Protoc; 2021 Jun; 2(2):100573. PubMed ID: 33997801 [TBL] [Abstract][Full Text] [Related]
11. Protocol for studying co-infection between SARS-CoV-2 and Staphylococcus aureus in vitro. Goncheva MI; Heinrichs DE STAR Protoc; 2023 Sep; 4(3):102411. PubMed ID: 37393614 [TBL] [Abstract][Full Text] [Related]
12. Protocol for global proteome, virome, and metaproteome profiling of respiratory specimen (VTM) in COVID-19 patient by LC-MS/MS-based analysis. Tripathi G; Sharma N; Bindal V; Yadav M; Mathew B; Sharma S; Gupta E; Singh Maras J; Sarin SK STAR Protoc; 2022 Mar; 3(1):101045. PubMed ID: 34870243 [TBL] [Abstract][Full Text] [Related]
13. A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19. Martin S; Jégou G; Nicolas A; Le Gallo M; Chevet É; Godey F; Avril T STAR Protoc; 2022 Mar; 3(1):101229. PubMed ID: 35287269 [TBL] [Abstract][Full Text] [Related]
14. Leveraging a self-cleaving peptide for tailored control in proximity labeling proteomics. Delhaye L; Moschonas GD; Fijalkowska D; Verhee A; De Sutter D; Van de Steene T; De Meyer M; Grzesik H; Van Moortel L; De Bosscher K; Jacobs T; Eyckerman S Cell Rep Methods; 2024 Jul; 4(7):100818. PubMed ID: 38986614 [TBL] [Abstract][Full Text] [Related]
15. Global metabolome profiling of COVID-19 respiratory specimen using high-resolution mass spectrometry (HRMS). Sharma N; Bhat SH; Tripathi G; Yadav M; Mathew B; Bindal V; Sharma S; Gupta E; Maras JS; Sarin SK STAR Protoc; 2022 Mar; 3(1):101051. PubMed ID: 34877545 [TBL] [Abstract][Full Text] [Related]
16. Identification of the interacting partners of a lysosomal membrane protein in living cells by BioID technique. Nguyen-Tien D; Suzuki T; Kobayashi T; Toyama-Sorimachi N; Dohmae N STAR Protoc; 2022 Jun; 3(2):101263. PubMed ID: 35403001 [TBL] [Abstract][Full Text] [Related]
17. An optimized, amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms. Bhoyar RC; Senthivel V; Jolly B; Imran M; Jain A; Divakar MK; Scaria V; Sivasubbu S STAR Protoc; 2021 Sep; 2(3):100755. PubMed ID: 34368787 [TBL] [Abstract][Full Text] [Related]
18. A miniTurbo-based proximity labeling protocol to identify conditional protein interactomes in vivo in Myxococcus xanthus. Herfurth M; Müller F; Søgaard-Andersen L; Glatter T STAR Protoc; 2023 Dec; 4(4):102657. PubMed ID: 37883223 [TBL] [Abstract][Full Text] [Related]